High flu activity continues in several parts of the world, especially in Australia, as well as some countries in southern Asia and southeast Asia, the World Health Organization (WHO) said in its latest global flu update.
The Saudi Arabian Ministry of Health (MOH) reported another new case of MERS-CoV in Riyadh today.
A 48-year-old male expatriate from the capital city was diagnosed as having MERS-CoV (Middle East respiratory syndrome coronavirus) after presenting with symptoms of the virus. He is in critical condition. The man's source of infection is listed as "pimary," meaning it's unlikely he contracted the virus from another person.
The World Health Organization (WHO) yesterday said French officials have notified it of a fatal yellow fever case in a 43-year-old Brazilian woman in French Guiana whose vaccination status isn't known.
In an ongoing multistate Cyclospora outbreak, 96 more patients without a history of international travel who were sick on or after May 1 have been reported to the US Centers for Disease Prevention and Control (CDC), boosting the national total to 347, according to the agency's latest update.
Also, the species might be resistant to cold temperatures.
The supply of Sanofi Pasteur's yellow fever vaccine YF-Vax is depleted in the United States until the middle of next year, the company said in a press release yesterday. Sanofi said the vaccine would be available again once Sanofi moves production to new "state of the art" facilities.
In a new study on the Ebola vaccine that has already shown effectiveness in an earlier phase 3 trial during West Africa's outbreak, researchers found that antibodies persist at least for a year and that the vaccine was well tolerated.
The World Health Organization's (WHO's) regional office for Africa released a new Ebola situation report today, noting fewer cases than previously reported in the Democratic Republic of the Congo (DRC).
The Florida study suggests a 'perfect storm' of conditions made Miami a favorable setting for Zika and that mosquito control helped reduce disease levels.
The yellow fever virus that has caused a large outbreak in Brazil has undergone substantial mutations, but these changes should not affect vaccine effectiveness, Brazilian investigators said, according to a story today in Brazil's O Globo newspaper.
